A 20-year-old female diagnosed as idiopathic pulmonary arterial hypertension at 7 years of age was referred with worsening dyspnea and chest pain. Several imaging studies and right cardiac catheterization showed multiple stenoses in the peripheral pulmonary arteries with severe pulmonary hypertension and multiple systemic arterial stenoses lacking in systemic hypertension. No evidence of inflammatory or autoimmune disease was detected. Fibromuscular dysplasia was clinically diagnosed because of the narrowed systemic and pulmonary arterial stenoses which included dilatation and aneurysms that appeared similar to a string of beads. Treatment with sildenafil yielded a temporary improvement in her disease state.
Introduction
Fibromuscular dysplasia (FMD) is a rare disease affecting the layers of small and medium size muscular arteries such as the renal or craniocervical artery. The etiology of FMD is still unknown, although FMD is pathologically characterized by circumferential or eccentric collagen deposition without an atherosclerotic and inflammatory component. Renal artery involvement is the most common manifestation of FMD (60-75%) and FMD is thought to be an important cause of systemic hypertension due to renal arterial stenosis (1) . FMD also affects craniocervical arteries (25-30%) (1) and sometimes causes Moya-moya disease because of intracerebral arterial occlusion. There are a few reports of FMD involving the pulmonary artery (2, 3) . This report presents a case of FMD with severe pulmonary hypertension due to multiple stenoses in the peripheral pulmonary arteries and with multiple systemic arterial stenoses lacking in systemic hypertension.
Case Report
A 20-year-old female previously diagnosed with idiopathic pulmonary arterial hypertension was referred to Chiba University Hospital with worsening dyspnea and chest pain.
She felt short of breath and looked pale on exertion at the age of three. She was diagnosed with mild idiopathic pulmonary arterial hypertension by the pediatrics department of a general hospital when she was 7 years old. Transthoracic echocardiography (TTE) revealed systolic pulmonary arterial pressure (Ppa) of about 35 mmHg. She had been treated with diuretics, aspirin, and digitalis since that time. Her dyspnea on exertion and chest pain gradually worsened. She was referred to the hospital for a reevaluation of the diagnosis and therapy at the age of 20.
Her systemic blood pressure showed a bilateral difference, left pulse of the radial artery was weaker than that of the right (right upper extremity: 128/57 mmHg; left upper extremity: 97/67 mmHg; right lower extremity: 134/64 mmHg; left lower extremity: 128/66 mmHg). TTE revealed that the estimated systolic Ppa increased to over 100 mmHg. The ar- terial oxygen tension was 87 mmHg at rest. The patient's 6-minute walk distance (6MWD) was 447 m; however oxygen saturation recorded by pulse oximeter was down from 97% to 87% at room air during walking. Pulmonary function tests showed that the FVC was 2.69 L (81.0% of predicted), FEV1 was 2.22 L, FEV1/FVC(%) was 65.1%, and diffusing capacity of the lung for monoxide was 78.9%. A lung perfusion scan revealed multiple segmental perfusion defects with a normal ventilation study ( Fig. 1 ). An enhanced chest multi-slice CT (MSCT) revealed no thrombi in her pulmonary artery but there were multiple segmental stenoses and abruptions of the peripheral pulmonary artery (Fig. 2) . MSCT also showed long smooth, concentric tubular stenosis of the aortic arch and descending aorta, and multiple segmental stenoses of those branches including the left subclavian artery and left common carotid artery (Fig. 3) . Right , and pulmonary arterial angiography showed stenoses of multiple arteries, which included dilatation and aneurysms that resembled a string of beads (Fig. 4) .
There was neither an episode of persistent fever of unknown origin nor evidence of inflammatory or autoimmune disease in her laboratory data (Table 1) . A carotid arterial ultrasound examination (CAUS) as well as CT showed a narrowing of the vascular lumen, but revealed no calcification of the vascular wall.
An enhanced abdominal MSCT showed long smooth, concentric tubular stenosis of the abdominal aorta, stenoses of the celiac and superior mesenteric artery, and segmental mild tubular stenosis of the right renal artery (Fig. 5) . A magnetic resonance angiography (MRA) revealed multiple irregular concentric stenoses in the cerebral blood vessels (Fig. 6) . The patient was re-diagnosed to have FMD involving the peripheral pulmonary artery and cerebral artery on the basis of these results. She was initially treated with bosentan and warfarin, but failed to show any improvement of her symptoms and she felt faint several times. Sildenafil was added to the bosentan and warfarin, and her symptoms and cardiac function improved (cardiac output estimated by TTE: 3.9 L/min to 5.8 L/min, BNP: 164.4 pg/mL to 54.5 pg/mL) with no significant change in the estimated Ppa by TTE (118 mmHg to 114 mmHg). However the estimated Ppa increased and her symptoms had gradually worsened after the 18-month follow-up.
Discussion
FMD is an important cause of renal hypertension due to its renal arterial involvement (1), but pulmonary hypertension caused by FMD is rare. In this case, there was a mild renal arterial lesion lacking systemic hypertension, however she developed pulmonary hypertension due to pulmonary arterial involvement of FMD.
The pathological diagnosis of FMD is often difficult because it is not easy to biopsy the arterial site of involvement. Earlier studies obtained a pathological diagnosis of FMD by a biopsy with surgical angioplasty or postmortem autopsy (2-4). Osborn and Anderson reported that the string of beads appearance at angiography may lead to the diagnosis of FMD even if a pathological diagnosis cannot be determined (5). Differential diagnoses might include an atherosclerotic, inflammatory arterial disease like Takayasu arteritis, Williams syndrome, vascular Ehlers-Danlos syndrome, and type 1 neurofibromatosis (1, 6). The current patient has not received a pathological diagnosis because she has not undergone surgical angioplasty or a vascular biopsy. MSCT angiography and MR angiography showed bilateral peripheral stenoses and abruptions of the peripheral pulmonary artery with dilatation and aneurysms with the string of beads appearance, long smooth and concentric tubular stenosis of the aorta, and multiple segmental stenoses of various systemic arteries.
The present patient was initially thought to have Takayasu arteritis involving the pulmonary artery. Takayasu arteritis is an inflammatory vascular disease involving both systemic and pulmonary artery (7). However, there was no history of either an episode of persistent fever of unknown origin or evidence of inflammatory and autoimmune disease in her laboratory data. In addition, CAUS and MSCT revealed no calcification of the narrowed vascular wall. Furthermore, earlier reports (8) (9) (10) (11) (12) (13) , indicate that Takayasu arteritis mainly affects the central pulmonary artery, and therefore Takayasu arteritis was excluded.
Williams Syndrome is caused by a hemizygous deletion in chromosome band 7q11.23, including the gene for elastin (14) . It is characterized by a typical facial appearance called elfin, supravalvular aortic stenosis, supravalvular and peripheral pulmonary arterial stenosis (15) , and delay of development. However, she did not show an elfin face or delay of development. Her karyotype revealed a normal pattern. Vascular Ehlers-Danlos syndrome, also known as type IV is a life-threatening autosomal dominant disorder of the connective tissue, caused by mutations of the COL3A1 gene (16) . There were no clinical features that fulfilled any of the major and minor criteria of vascular Ehlers-Danlos syndrome (17) . She showed no cutaneous disorder suggesting Type 1 neurofibromatosis (18). Finally she was diagnosed to have FMD with severe pulmonary hypertension but lacking in systemic hypertension based on the characteristic angiographic findings of FMD and the exclusion of other diseases.
No standardized treatment for pulmonary hypertension associated with FMD has been established and no report of the medication therapy is found. Sildenafil has been reported to effectively to improve cardiac function as well as to decrease pulmonary hypertension (19) . Sildenafil was transiently effective because her symptoms and cardiac function improved, but the long-term effect was minimal. Successful dilatation of renal arterial stenosis due to FMD by catheter intervention has been reported (20) (21) (22) , however there are few reports of catheter intervention to pulmonary arterial stenoses. de Vries et al reported a case of FMD with Moyamoya syndrome and pulmonary hypertension due to pulmonary arterial involvement but the patient died of severe pulmonary hemorrhage associated with the catheter intervention (2). The major adverse effects of catheter intervention for chronic thromboembolic pulmonary hypertension are reported to be reperfusion injury in addition to perforation of the pulmonary artery (22) . Non-invasive positive airway pressure ventilation might be helpful for reperfusion injury after catheter intervention as well as acute respiratory distress syndrome (23, 24) . Further improvements must therefore be made in the management of catheter intervention for the successful treatment of the current patient's pulmonary arterial stenoses.
